BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1688186)

  • 1. Somatostatin analogs: their role in the treatment of growth hormone hypersecretion and excessive body growth.
    Lamberts SW
    Growth Regul; 1991 Mar; 1(1):3-10. PubMed ID: 1688186
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible shrinkage of a growth hormone-secreting pituitary adenoma by a long-acting somatostatin analogue, octreotide.
    Barakat S; Melmed S
    Arch Intern Med; 1989 Jun; 149(6):1443-5. PubMed ID: 2730266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group.
    Vance ML; Harris AG
    Arch Intern Med; 1991 Aug; 151(8):1573-8. PubMed ID: 1872661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone excess and the effect of octreotide in cats with diabetes mellitus.
    Slingerland LI; Voorhout G; Rijnberk A; Kooistra HS
    Domest Anim Endocrinol; 2008 Nov; 35(4):352-61. PubMed ID: 18801640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current therapeutic possibilities with growth hormone releasing hormone and somatostatin].
    Lamberts SW
    Ned Tijdschr Geneeskd; 1986 May; 130(20):904-8. PubMed ID: 2873514
    [No Abstract]   [Full Text] [Related]  

  • 6. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones.
    George SR; Hegele RA; Burrow GN
    Clin Invest Med; 1987 Jul; 10(4):309-15. PubMed ID: 2888554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term treatment of acromegaly with the somatostatin analog octreotide (Sandostatin). On the predictive significance of acute tests].
    Schmidt K; Althoff PH; Harris A; Hofmeister-Wagner W; Schifferdecker E; Schöffling K
    Med Klin (Munich); 1990 Dec; 85(12):700-6. PubMed ID: 2128367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of acromegaly with a long-acting analogue of somatostatin, octreotide.
    Page MD; Millward ME; Taylor A; Preece M; Hourihan M; Hall R; Scanlon MF
    Q J Med; 1990 Feb; 74(274):189-201. PubMed ID: 2111918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.
    N Engl J Med; 1986 May; 314(21):1390-2. PubMed ID: 2871490
    [No Abstract]   [Full Text] [Related]  

  • 11. Octreotide treatment of acromegaly during pregnancy.
    Mikhail N
    Mayo Clin Proc; 2002 Mar; 77(3):297-8. PubMed ID: 11888040
    [No Abstract]   [Full Text] [Related]  

  • 12. Another case where bigger is not better.
    Weber KT
    Cardiovasc Res; 1997 Oct; 36(1):1-2. PubMed ID: 9415265
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose and frequency titration of somatostatin analogues in the treatment of acromegaly - an injection of expediency?
    James RA; Gilroy J
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):11-3. PubMed ID: 11167919
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical therapy with somatostatin analogues for acromegaly.
    Sassolas G
    Eur J Endocrinol; 1995 Dec; 133(6):675-7. PubMed ID: 8548050
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of high dose somatostatin analogue on growth hormone concentrations in acromegaly.
    Sandler LM; Burrin JM; Joplin GF; Bloom SR
    Br Med J (Clin Res Ed); 1988 Mar; 296(6624):751-2. PubMed ID: 2894886
    [No Abstract]   [Full Text] [Related]  

  • 16. Octreotide is effective in acromegaly but often results in cholelithiasis.
    Daughaday WH
    Ann Intern Med; 1990 Feb; 112(3):159-60. PubMed ID: 2404444
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical treatment of acromegaly. Somatostatin analogs offer a real hope].
    Kuhn JM; Héron I
    Rev Prat; 1992 Nov; 42(18):2303-7. PubMed ID: 1363585
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary therapy for acromegaly with somatostatin analogs and a discussion of novel peptide analogs.
    Kleinberg DL
    Rev Endocr Metab Disord; 2005 Jan; 6(1):29-37. PubMed ID: 15711912
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical applications of somatostatin analogs.
    Marbach P; Neufeld M; Pless J
    Adv Exp Med Biol; 1985; 188():339-53. PubMed ID: 2863941
    [No Abstract]   [Full Text] [Related]  

  • 20. Is presurgical treatment with somatostatin analogs necessary in acromegalic patients?
    Losa M; Mortini P; Giovanelli M
    J Endocrinol Invest; 1999 Dec; 22(11):871-3. PubMed ID: 10710277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.